Publicaciones científicas

NADPH Oxidase 5 (NOX5) Overexpression Promotes Endothelial Dysfunction via Cell Apoptosis, Migration, and Metabolic Alterations in Human Brain Microvascular Endothelial Cells (hCMEC/D3)

29-oct-2022 | Revista: Antioxidants

Javier Marqués 1 2, Joaquín Fernández-Irigoyen 1 3, Elena Ainzúa 1 2, María Martínez-Azcona 1 2, Adriana Cortés 1 2, Carmen Roncal 1 4 5, Josune Orbe 1 4 6, Enrique Santamaría 1 3, Guillermo Zalba 1 2


NADPH oxidases (NOX) constitute the main reactive oxygen species (ROS) source in blood vessels. An oxidative stress situation due to ROS overproduction can lead into endothelial dysfunction, a molecular mechanism that precedes cardiovascular diseases (CVDs) such as atherosclerosis, myocardial infarction, and stroke. NOX5 is the last discovered member of the NOX family, studied in a lesser extent due to its absence in the rodent genome.

Our objective was to describe the phenotypic alterations produced by an oxidative stress situation derived from NOX5 overexpression in an endothelial in vitro model.

The in vitro model consists of the hCMEC/D3 cell line, derived from brain microvascular endothelium, infected with a recombinant NOX5-β adenovirus. After an initial proteomic analysis, three phenotypic alterations detected in silico were studied: cell proliferation and apoptosis, general and mitochondrial metabolism, and migration capacity. NOX5 infection of hCMEC/D3 generates a functional protein and an increase in ROS production.This model produced changes in the whole cell proteome.

The in silico analysis together with in vitro validations demonstrated that NOX5 overexpression inhibits proliferation and promotes apoptosis, metabolic alterations and cell migration in hCMEC/D3 cells. NOX5 overexpression in endothelial cells leads to phenotypic changes that can lead to endothelial dysfunction, the onset of atherosclerosis, myocardial infarction, and stroke.

Keywords: NADPH oxidase 5; cardiovascular diseases; cell migration; cell proliferation; endothelial cells; endothelial dysfunction; mitochondrial dysfunction.

CITA DEL ARTÍCULO  Antioxidants (Basel) . 2022 Oct 29;11(11):2147. doi: 10.3390/antiox11112147.

Nuestros autores

Dra. Carmen Roncal Mancho
Dra. Josune Orbe Lopategui